Immunovia AB (IMMVF)
OTHER OTC:IMMVF
Holding IMMVF?
Track your performance easily

Immunovia AB (IMMVF) Income Statement

4 Followers

Immunovia AB Income Statement

Last quarter (Q3 2022), Immunovia AB's total revenue was kr358.00K, a decrease of -5.04% from the same quarter last year. In Q3, Immunovia AB's net income was kr-22.93M. See Immunovia AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
kr 948.00Kkr 844.00Kkr 362.00Kkr 356.00Kkr 333.00Kkr 148.96K
Cost of Revenue
kr 4.15Mkr -14.97Mkr -40.02Mkr -26.72Mkr -25.05Mkr -24.04M
Gross Profit
kr -3.20Mkr 15.81Mkr 40.38Mkr 27.07Mkr 25.39Mkr 24.19M
Operating Expense
kr 187.86Mkr 182.55Mkr 175.06Mkr 141.42Mkr 113.62Mkr 69.77M
Operating Income
kr -191.06Mkr -166.74Mkr -134.68Mkr -114.35Mkr -88.23Mkr -45.58M
Net Non Operating Interest Income Expense
kr 31.66Mkr -722.00Kkr -842.00Kkr -1.03Mkr 318.00Kkr 287.56K
Other Income Expense
------
Pretax Income
kr -147.90Mkr -155.97Mkr -146.03Mkr -114.52Mkr -86.53Mkr -45.23M
Tax Provision
-kr 0.00kr 0.00kr 4.00Kkr 7.00Kkr 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
kr -147.90Mkr -155.97Mkr -146.03Mkr -114.52Mkr -86.54Mkr -45.23M
Basic EPS
kr -6.46kr -6.89kr -6.84kr -5.85kr -4.67kr -2.67
Diluted EPS
kr -6.46kr -6.89kr -6.84kr -5.85kr -4.67kr -2.67
Basic Average Shares
kr 92.28Mkr 22.63Mkr 21.34Mkr 19.57Mkr 18.55Mkr 16.93M
Diluted Average Shares
kr 92.28Mkr 22.63Mkr 21.34Mkr 19.57Mkr 18.55Mkr 16.93M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
-kr 62.00Kkr 71.00Kkr 71.00K--
Total Expenses
kr 192.01Mkr 167.59Mkr 135.04Mkr 114.71Mkr 88.56Mkr 45.73M
Net Income From Continuing And Discontinued Operation
kr -147.90Mkr -155.97Mkr -146.03Mkr -114.52Mkr -86.54Mkr -45.23M
Normalized Income
kr -147.90Mkr -155.97Mkr -146.03Mkr -114.52Mkr -86.54Mkr -45.23M
Interest Expense
kr -802.00Kkr 1.43Mkr 1.42Mkr 1.32Mkr 1.00Kkr 10.17K
EBIT
kr -148.70Mkr -154.53Mkr -144.62Mkr -113.20Mkr -86.53Mkr -45.22M
EBITDA
kr -123.83Mkr -135.47Mkr -134.85Mkr -104.75Mkr -83.75Mkr -43.96M
Currency in SEK

Immunovia AB Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis